Benitec Biopharma Inc. BNTC
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Benitec Biopharma Inc. is a clinical-stage biotechnology company focused on developing novel genetic medicines for chronic and life-threatening conditions. It employs its proprietary Silence and Replace platform, which combines DNA-directed RNA interference with gene therapy to enable sustained silencing of disease-cau…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees19
TickerBNTC
Statistics
Market Cap$405.0M
Revenue (TTM)—
Net Income-$37.9M
Net Margin—
EPS$-1.05
P/E-10.66
P/S—
P/B2.07
EV/EBITDA-3.72
ROE-29.6%
Dividend Yield—
Price$11.79
Data: Twelve Data · Revenue = mcap / P/S